34 Results for



Venter introduces X Prize to sequence centenarians' DNA

Craig Venter helps launch the Archon Genomics X Prize, which will award $10 million to the first team to sequence the genomes of 100 centenarians to a level of accuracy never before achieved and at relatively low cost.

By October 26, 2011


Researchers sequence cancer-resistant rodent's DNA

Humans might benefit from better understanding the naked mole-rat, which boasts a lack-of-pain sensation in its skin, and resistance to both aging and disease.

By July 5, 2011


Proton promises us $1,000 genome mapping by year end

At CES, Life Technologies' Ion Torrent unveils a benchtop device that by year-end should decode a full human genome in one day for $1,000.

By January 10, 2012


2012 an in-between year for digital health at CES

Much of the health and wellness tech was either already in the works in 2011 or too early to be demoed in 2012.

By January 13, 2012


For a moment, antimicrobial Toddy cloth steals the show

The Toddy Smart Cloth for cleaning and polishing glasses and screens draws a crowd of CES attendees wielding some pretty dirty touch screens.

By January 12, 2012


What mattered on CES Day 1

On the first official day of the Consumer Electronics Show, the steady flow of new product announcements continues. Here's the stuff we think is worth seeing.

By January 10, 2012


iPad 2 music video tests GarageBand and iMovie to the limit

We put the new GarageBand and iMovie iPad apps to the test -- can we create a CNET UK music video using only these music and video apps?

By April 26, 2011


IBM Research jumps into genetic sequencing

Big Blue hopes its electronic automation technology will give people and their doctors individual genetic records for less than $1,000.

By October 5, 2009


Crazy-looking sequencer app for iPhone

JR Hexatone Pro was created by Noise.io developers Amidio in conjunction with Dream Theater keyboardist Jordan Ruess.

By August 7, 2009


Want a prescription? 'X-ray' your genes first

Researchers in Israel are using a deep sequencer to look at how the genetic expressions of microRNAs will affect any given patient's reaction to medications.

By October 8, 2010